Core Laboratories (CLB) Expected to Announce Quarterly Earnings on Wednesday

Core Laboratories (NYSE:CLBGet Free Report) is expected to be announcing its Q3 2025 results after the market closes on Wednesday, October 22nd. Analysts expect the company to announce earnings of $0.18 per share and revenue of $130.9240 million for the quarter. Core Laboratories has set its Q3 2025 guidance at 0.180-0.220 EPS.Interested persons may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, October 23, 2025 at 8:30 AM ET.

Core Laboratories (NYSE:CLBGet Free Report) last released its earnings results on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.01. The company had revenue of $130.16 million during the quarter, compared to the consensus estimate of $129.19 million. Core Laboratories had a return on equity of 14.15% and a net margin of 5.73%.The firm’s quarterly revenue was down .3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.22 earnings per share. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Trading Up 4.4%

CLB stock opened at $11.84 on Tuesday. The company has a market cap of $555.32 million, a P/E ratio of 19.10, a PEG ratio of 6.27 and a beta of 1.38. Core Laboratories has a twelve month low of $9.72 and a twelve month high of $21.83. The company has a quick ratio of 1.70, a current ratio of 2.27 and a debt-to-equity ratio of 0.47. The business has a fifty day moving average of $11.74 and a 200-day moving average of $11.73.

Core Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, August 25th. Stockholders of record on Monday, August 4th were given a dividend of $0.01 per share. The ex-dividend date was Monday, August 4th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.3%. Core Laboratories’s payout ratio is presently 6.45%.

Institutional Trading of Core Laboratories

Several institutional investors and hedge funds have recently added to or reduced their stakes in CLB. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Core Laboratories by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock worth $418,000 after acquiring an additional 1,170 shares in the last quarter. American Century Companies Inc. raised its position in Core Laboratories by 14.3% during the second quarter. American Century Companies Inc. now owns 133,033 shares of the oil and gas company’s stock worth $1,533,000 after acquiring an additional 16,677 shares in the last quarter. Quantbot Technologies LP raised its position in Core Laboratories by 343.7% during the second quarter. Quantbot Technologies LP now owns 17,520 shares of the oil and gas company’s stock worth $202,000 after acquiring an additional 13,571 shares in the last quarter. Sei Investments Co. bought a new stake in Core Laboratories during the second quarter worth $231,000. Finally, The Manufacturers Life Insurance Company raised its position in Core Laboratories by 6.2% during the second quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock worth $207,000 after acquiring an additional 1,040 shares in the last quarter. 97.81% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently weighed in on CLB. Wall Street Zen upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, July 26th. Zacks Research upgraded Core Laboratories from a “strong sell” rating to a “hold” rating in a research report on Friday, August 15th. Stifel Nicolaus dropped their target price on Core Laboratories from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Wednesday, July 16th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Core Laboratories in a report on Wednesday, October 8th. Three research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Core Laboratories currently has an average rating of “Reduce” and an average price target of $12.50.

Check Out Our Latest Stock Report on Core Laboratories

Core Laboratories Company Profile

(Get Free Report)

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.

See Also

Earnings History for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.